What it sells
Automation of herbal-medicine manufacturing
Business model breakdown
Buyer: who owns the budget?
UnverifiedOwner or director of a Korean-medicine clinic or pharmacy.
Trigger: what makes them buy now?
UnverifiedClinics, pharmacies and wellness brands wanting precise, consistent in-house herbal/natural formulations (0.1 g dispensing, HPLC checks) without building their own GMP production.
Workflow: what inputs become what output?
Clinic service supports the whole clinic process: consultation, prescription, compounding/dispensing and patient management, with automated precision compounding (0.1 g units) and HPLC quality analysis.
Economics: what it saves and how it charges
Revenue from OEM/ODM contract manufacturing and B2B formulation, plus wholesale/retail franchise business and branding/package design services; prices not disclosed.
Distribution: how it reaches customers
B2B direct sales to clinics plus company-branded premium pharmacies (OWNHERB Pharmacy) and a wholesale/retail franchise business; OEM/ODM inquiries via contact form.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-08-06 | Series A | KRW 6.2B | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-13.